AN UNBIASED VIEW OF PSYCHEDELICS

an assessment by FDA experts, printed forward from the June Assembly, also raised considerations about how the trials had been carried out, like that numerous patients and therapists most likely had been capable to guess who was provided the medication and who received the placebo. Hallucinogen persisting notion dysfunction (HPPD)—the recurring